Associations of Clinical Characteristics and Intestinal Flora Imbalance in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients and the Construction of an Early Warning Model

References

• Riley CM, Sciurba FC. Diagnosis and outpatient management of chronic obstructive pulmonary disease: a review. JAMA. 2019;321(8):786–797. doi:10.1001/jama.2019.0131
   PubMed Web of Science ®Google Scholar
• Iheanacho I, Zhang S, King D, et al. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–460. doi:10.2147/COPD.S234942
   PubMed Web of Science ®Google Scholar
• Wu YK, Lan CC, Tzeng IS, et al. The COPD-readmission (CORE) score: a novel prediction model for one-year chronic obstructive pulmonary disease readmissions. J Formos Med Assoc. 2021;120(3):1005–1013. doi:10.1016/j.jfma.2020.08.043
   PubMed Web of Science ®Google Scholar
• Anees UR, Ahmad Hassali MA, Muhammad SA, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature. Expert Rev Pharmacoecon Outcomes Res. 2020;20(6):661–672. doi:10.1080/14737167.2020.1678385
   PubMed Web of Science ®Google Scholar
• Mayhew D, Devos N, Lambert C, et al. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 2018;73(5):422–430. doi:10.1136/thoraxjnl-2017-210408
   PubMed Web of Science ®Google Scholar
• Ottiger M, Nickler M, Steuer C, et al. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease. Nutrition. 2018;45:135–141 e131. doi:10.1016/j.nut.2017.07.001
   PubMed Web of Science ®Google Scholar
• Sun Z, Zhu QL, Shen Y, et al. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations. Kaohsiung J Med Sci. 2020;36(2):107–113. doi:10.1002/kjm2.12147
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu C, Lu W, et al. Clinical characteristics and risk factors of pulmonary hypertension associated with chronic respiratory diseases: a retrospective study. J Thorac Dis. 2016;8(3):350–358. doi:10.21037/jtd.2016.02.58
   PubMed Web of Science ®Google Scholar
• Cheng SL, Lin CH, Wang CC, et al. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients. J Formos Med Assoc. 2019;118(1 Pt 3):429–435. doi:10.1016/j.jfma.2018.06.018
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• Miravitlles M, Vogelmeier C, Roche N, et al. A review of national guidelines for management of COPD in Europe. Eur Respir J. 2016;47(2):625–637. doi:10.1183/13993003.01170-2015
   PubMed Web of Science ®Google Scholar
• Tuddenham S, Sears CL. The intestinal microbiome and health. Curr Opin Infect Dis. 2015;28(5):464–470. doi:10.1097/QCO.0000000000000196
   PubMed Web of Science ®Google Scholar
• Kostidis S, Kokova D, Dementeva N, et al. 1 H-NMRanalysis of feces: new possibilities in the helminthes infections research. BMC Infect Dis. 2017;17(1):275. doi:10.1186/s12879-017-2351-7
   PubMedGoogle Scholar
• Zaika S, Paliy I, Chernobrovyi V, et al. The study and comparative analysis of GerdQ and GSRS Questionnaires on gastroesophageal reflux disease diagnostics. Prz Gastroenterol. 2020;15(4):323–329. doi:10.5114/pg.2020.101561
   PubMed Web of Science ®Google Scholar
• Yamaya M, Usami O, Nakayama S, et al. Malnutrition, airflow limitation and severe emphysema are risks for exacerbation of chronic obstructive pulmonary disease in Japanese subjects: a retrospective single-center study. Int J Chron Obstruct Pulmon Dis. 2020;15:857–868. doi:10.2147/COPD.S238457
   PubMed Web of Science ®Google Scholar
• Kim EK, Singh D, Park JH, et al. Impact of body mass index change on the prognosis of chronic obstructive pulmonary disease. Respiration. 2020;99(11):943–953. doi:10.1159/000511022
   PubMed Web of Science ®Google Scholar
• Chen R, Xing L, You C, et al. Prediction of prognosis in chronic obstructive pulmonary disease patients with respiratory failure: a comparison of three nutritional assessment methods. Eur J Intern Med. 2018;57:70–75. doi:10.1016/j.ejim.2018.06.006
   PubMed Web of Science ®Google Scholar
• Zinellu E, Fois AG, Sotgiu E, et al. Serum albumin concentrations in stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Clin Med. 2021;10:2. doi:10.3390/jcm10020269
   Web of Science ®Google Scholar
• Sprooten RTM, Lenaerts K, Braeken DCW, et al. Increased small intestinal permeability during severe acute exacerbations of COPD. Respiration. 2018;95(5):334–342. doi:10.1159/000485935
   PubMed Web of Science ®Google Scholar
• Qin J, Qin Y, Wu Y, et al. Application of albumin/globulin ratio in elderly patients with acute exacerbation of chronic obstructive pulmonary disease. J Thorac Dis. 2018;10(8):4923–4930. doi:10.21037/jtd.2018.07.47
   PubMed Web of Science ®Google Scholar
• Montagnani A, Mathieu G, Pomero F, et al. Hospitalization and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD): an Italian population-based study. Eur Rev Med Pharmacol Sci. 2020;24(12):6899–6907. doi:10.26355/eurrev_202006_21681
   PubMed Web of Science ®Google Scholar
• Spece LJ, Epler EM, Donovan LM, et al. Role of comorbidities in treatment and outcomes after chronic obstructive pulmonary disease exacerbations. Ann Am Thorac Soc. 2018;15(9):1033–1038. doi:10.1513/AnnalsATS.201804-255OC
   PubMed Web of Science ®Google Scholar
• Niklasson A, Strid H, Simren M, et al. Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease. Eur J Gastroenterol Hepatol. 2008;20(4):335–341. doi:10.1097/MEG.0b013e3282f2d0ec
   PubMed Web of Science ®Google Scholar
• Rutten EPA, Lenaerts K, Buurman WA, et al. Disturbed intestinal integrity in patients with COPD: effects of activities of daily living. Chest. 2014;145(2):245–252. doi:10.1378/chest.13-0584
   PubMed Web of Science ®Google Scholar
• Zareifopoulos N, Bellou A, Spiropoulou A, et al. Prevalence, contribution to disease burden and management of comorbid depression and anxiety in chronic obstructive pulmonary disease: a narrative review. COPD. 2019;16(5–6):406–417. doi:10.1080/15412555.2019.1679102
   PubMedGoogle Scholar
• Zheng S, Zhu Y, Wu W, et al. A correlation study of intestinal microflora and first-episode depression in Chinese patients and healthy volunteers. Brain Behav. 2021;11(8):e02036. doi:10.1002/brb3.2036
   PubMed Web of Science ®Google Scholar
• Su KC, Ko HK, Chou KT, et al. An accurate prediction model to identify undiagnosed at-risk patients with COPD: a cross-sectional case-finding study. NPJ Prim Care Respir Med. 2019;29(1):22. doi:10.1038/s41533-019-0135-9
   PubMedGoogle Scholar
• Lee SJ, Yun SS, Ju S, et al. Validity of the GOLD 2017 classification in the prediction of mortality and respiratory hospitalization in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:911–919. doi:10.2147/COPD.S191362
   PubMed Web of Science ®Google Scholar
• Kim J, Lee CH, Hwang SS, et al. The ability of different scoring systems to predict mortality in chronic obstructive pulmonary disease patients: a prospective cohort study. Respiration. 2019;98(6):495–502. doi:10.1159/000502826
   PubMed Web of Science ®Google Scholar